Company Tracker: Pfizer turns to acquisitions as Covid products’ sales nosedive
Over the last five years, a
lot has changed for Pfizer Inc, one of the world’s leading pharma
DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings
In 2022, the world finally began to emerge out of Covid-related
restrictions. Though 2020 and 2021
DMF submissions in 2021: India, China continue to top filings
The year
2021 was eclipsed by the Covid-19 pandemic. In our update for the first half of 2020, we h
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More
After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center
US DMF filings indicate a robust API industry, with multiple first-to-file challenges
This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at
Generic challenges, the next first-to-files, GDUFA dues (FY 2016) and more
PharmaCompass has assessed the second quarter US Drug Master
File (DMFs) filings. In our view, with